{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T14:17:10Z","timestamp":1794838630062,"version":"4.9.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007366","name":"Italian Multiple Sclerosis Foundation","doi-asserted-by":"publisher","award":["2017\/R\/1"],"award-info":[{"award-number":["2017\/R\/1"]}],"id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013013","name":"Target ALS Foundation Inc","doi-asserted-by":"publisher","award":["BSP-TAL006"],"award-info":[{"award-number":["BSP-TAL006"]}],"id":[{"id":"10.13039\/100013013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2017NSXP8J"],"award-info":[{"award-number":["2017NSXP8J"]}],"id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007802","name":"AriSLA","doi-asserted-by":"publisher","award":["GPR17ALS-1"],"award-info":[{"award-number":["GPR17ALS-1"]}],"id":[{"id":"10.13039\/501100007802","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007802","name":"AriSLA","doi-asserted-by":"publisher","award":["GPR17ALS"],"award-info":[{"award-number":["GPR17ALS"]}],"id":[{"id":"10.13039\/501100007802","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007802","name":"AriSLA","doi-asserted-by":"publisher","award":["DORALS"],"award-info":[{"award-number":["DORALS"]}],"id":[{"id":"10.13039\/501100007802","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.phrs.2026.108424","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:20:51Z","timestamp":1788222051000},"page":"108424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Selective targeting of the oligodendroglial GPR17 receptor improves myelin integrity and motor function in female SOD1G93A mice"],"prefix":"10.1016","volume":"232","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2734-5418","authenticated-orcid":false,"given":"Stefano","family":"Raffaele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Bonifacino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Carolina","family":"Mannella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhung","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Torazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Marangon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Maria","family":"Chinosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Daa","family":"Schr\u00f8der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Kildall","family":"Hejb\u00f8l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Letizia","family":"Trincavelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Milanese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Lecca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate Lykke","family":"Lambertsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giambattista","family":"Bonanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria P.","family":"Abbracchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2026.108424_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Brown","year":"2017","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.phrs.2026.108424_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","article-title":"Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation","volume":"22","author":"Mead","year":"2023","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.phrs.2026.108424_bib3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/glia.24622","article-title":"Towards an integrated approach for understanding glia in Amyotrophic Lateral Sclerosis","volume":"73","author":"Majewski","year":"2025","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2026.108424_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3390\/cells10030565","article-title":"Oligodendrocyte Dysfunction in Amyotrophic Lateral Sclerosis: Mechanisms and Therapeutic Perspectives","volume":"10","author":"Raffaele","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2026.108424_bib5","article-title":"Revisiting oligodendrocytes in amyotrophic lateral sclerosis using human multicellular stem cell models","author":"Mouhi","year":"2025","journal-title":"Trends Cell. Biol."},{"key":"10.1016\/j.phrs.2026.108424_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1375330","article-title":"Oligodendrocytes in amyotrophic lateral sclerosis and frontotemporal dementia: the new players on stage","volume":"17","author":"Jamet","year":"2024","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.phrs.2026.108424_bib7","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nn.3357","article-title":"Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis","volume":"16","author":"Kang","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2026.108424_bib8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/brain\/aws339","article-title":"Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis","volume":"136","author":"Philips","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2026.108424_bib9","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3390\/ijms21072395","article-title":"Abnormal Upregulation of GPR17 Receptor Contributes to Oligodendrocyte Dysfunction in SOD1 G93A Mice","volume":"21","author":"Bonfanti","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108424_bib10","first-page":"1","article-title":"Regulation and signaling of the GPR17 receptor in oligodendroglial cells","volume":"2","author":"Lecca","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2026.108424_bib11","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.tips.2025.05.001","article-title":"GPR17 \u2013 orphan G protein-coupled receptor with therapeutic potential","volume":"46","author":"Lewash","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2026.108424_bib12","doi-asserted-by":"crossref","first-page":"10593","DOI":"10.1074\/jbc.M110.162867","article-title":"Phenotypic changes, signaling pathway, and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiation","volume":"286","author":"Fumagalli","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2026.108424_bib13","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.3390\/cells11152369","article-title":"Rewiring of Glucose and Lipid Metabolism Induced by G Protein-Coupled Receptor 17 Silencing Enables the Transition of Oligodendrocyte Progenitors to Myelinating Cells","volume":"11","author":"Marangon","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2026.108424_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106315","article-title":"G protein-coupled receptor 17 is regulated by WNT pathway during oligodendrocyte precursor cell differentiation","volume":"187","author":"Boccazzi","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2026.108424_bib15","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nn.2410","article-title":"The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination","volume":"12","author":"Chen","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2026.108424_bib16","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/glia.22896","article-title":"The ubiquitin ligase Mdm2 controls oligodendrocyte maturation by intertwining mTOR with G protein-coupled receptor kinase 2 in the regulation of GPR17 receptor desensitization","volume":"63","author":"Fumagalli","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2026.108424_bib17","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1038\/sj.emboj.7601341","article-title":"The orphan receptor GPR17 identified as a new dual uracil nucleotides\/cysteinyl-leukotrienes receptor","volume":"25","author":"Ciana","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2026.108424_bib18","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.cellsig.2014.08.003","article-title":"Oxysterols act as promiscuous ligands of class-A GPCRs: In silico molecular modeling and in vitro validation","volume":"26","author":"Sensi","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.phrs.2026.108424_bib19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bph.15969","article-title":"Identification and characterization of select oxysterols as ligands for GPR17","volume":"180","author":"Harrington","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108424_bib20","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1111\/bph.16408","article-title":"Montelukast improves disease outcome in SOD1 G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity","volume":"181","author":"Raffaele","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108424_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1124\/jpet.110.178715","article-title":"Agonist-induced desensitization\/resensitization of human G protein-coupled receptor 17: A functional cross-talk between purinergic and cysteinyl- leukotriene ligands","volume":"338","author":"Daniele","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2026.108424_bib22","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.cellsig.2014.02.016","article-title":"Does GRK-\u03b2 arrestin machinery work as a \u201cswitch on\u201d for GPR17-mediated activation of intracellular signaling pathways?","volume":"26","author":"Daniele","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.phrs.2026.108424_bib23","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3389\/fchem.2019.00910","article-title":"Surface Plasmon Resonance as a Tool for Ligand Binding Investigation of Engineered GPR17 Receptor, a G Protein Coupled Receptor Involved in Myelination","volume":"7","author":"Capelli","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.phrs.2026.108424_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231483","article-title":"Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: A novel disease-modifying strategy for multiple sclerosis","volume":"15","author":"Parravicini","year":"2020","journal-title":"PLoS. One"},{"key":"10.1016\/j.phrs.2026.108424_bib25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41593-022-01205-3","article-title":"Integrative transcriptomic analysis of the amyotrophic lateral sclerosis spinal cord implicates glial activation and suggests new risk genes","volume":"26","author":"Humphrey","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2026.108424_bib26","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.immuni.2025.02.024","article-title":"Single-cell transcriptomic and functional studies identify glial state changes and a role for inflammatory RIPK1 signaling in ALS pathogenesis","volume":"58","author":"Zelic","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2026.108424_bib27","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/path.6381","article-title":"Characterisation of <scp>GPR17<\/scp> -expressing oligodendrocyte precursors in human ischaemic lesions and correlation with reactive glial responses","volume":"265","author":"Raffaele","year":"2025","journal-title":"J. Pathol."},{"key":"10.1016\/j.phrs.2026.108424_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-020-00957-y","article-title":"Characterization of the TNF and IL-1 systems in human brain and blood after ischemic stroke","volume":"8","author":"Clausen","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.phrs.2026.108424_bib29","first-page":"1772","article-title":"Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science (1979)"},{"key":"10.1016\/j.phrs.2026.108424_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.nbd.2019.05.007","article-title":"In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"129","author":"Bonifacino","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2026.108424_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/21678421.2015.1047455","article-title":"State of the field: An informatics-based systematic review of the SOD1-G93A amyotrophic lateral sclerosis transgenic mouse model","volume":"17","author":"Kim","year":"2016","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"10.1016\/j.phrs.2026.108424_bib32","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.nbd.2016.07.011","article-title":"Altered mechanisms underlying the abnormal glutamate release in amyotrophic lateral sclerosis at a pre-symptomatic stage of the disease","volume":"95","author":"Bonifacino","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2026.108424_bib33","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1111\/bph.15193","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"177","author":"Percie du Sert","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108424_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020582","article-title":"One universal common endpoint in mouse models of amyotrophic lateral sclerosis","volume":"6","author":"Solomon","year":"2011","journal-title":"PLoS. One"},{"key":"10.1016\/j.phrs.2026.108424_bib35","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1111\/bph.15515","article-title":"Blocking glutamate mGlu5 receptors with the negative allosteric modulator CTEP improves disease course in SOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"178","author":"Milanese","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108424_bib36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/17482960701292837","article-title":"Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS\/MND: Report on the 142nd ENMC international workshop","volume":"8","author":"Ludolph","year":"2007","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.phrs.2026.108424_bib37","doi-asserted-by":"crossref","DOI":"10.3791\/2376","article-title":"Assessment of motor balance and coordination in mice using the balance beam","author":"Luong","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.phrs.2026.108424_bib38","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.ymthe.2020.12.009","article-title":"Microglial vesicles improve post-stroke recovery by preventing immune cell senescence and favoring oligodendrogenesis","volume":"29","author":"Raffaele","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phrs.2026.108424_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00745","article-title":"TNFR2 signaling shapes the sex-specific remyelinating properties of microglia after experimental stroke","volume":"22","author":"Raffaele","year":"2025","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.phrs.2026.108424_bib40","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s10571-020-01014-x","article-title":"Prenatal Stress Impairs Spinal Cord Oligodendrocyte Maturation via BDNF Signaling in the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis","volume":"42","author":"Paladini","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2026.108424_bib41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s44303-025-00098-8","article-title":"Label-free and fluorescence imaging of oligodendrocytes and myelin","volume":"3","author":"Kamen","year":"2025","journal-title":"Npj Imaging"},{"key":"10.1016\/j.phrs.2026.108424_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2024.1408182","article-title":"Reflective imaging of myelin integrity in the human and mouse central nervous systems","volume":"18","author":"Craig","year":"2024","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.phrs.2026.108424_bib43","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10822-011-9455-8","article-title":"silico identification of new ligands for GPR17: A promising therapeutic target for neurodegenerative diseases","volume":"25","author":"Eberini","year":"2011","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.phrs.2026.108424_bib44","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.it.2024.08.003","article-title":"Disease-associated oligodendroglia: a putative nexus in neurodegeneration","volume":"45","author":"Castelo-Branco","year":"2024","journal-title":"Trends Immunol."},{"key":"10.1016\/j.phrs.2026.108424_bib45","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.3390\/ijms22094574","article-title":"The distribution of gpr17-expressing cells correlates with white matter inflammation status in brain tissues of multiple sclerosis patients","volume":"22","author":"Angelini","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108424_bib46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.phrs.2019.02.025","article-title":"Improvement of fiber connectivity and functional recovery after stroke by montelukast, an available and safe anti-asthmatic drug","volume":"142","author":"Gelosa","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2026.108424_bib47","doi-asserted-by":"crossref","first-page":"19365","DOI":"10.1021\/acs.jmedchem.4c01755","article-title":"Discovery of Anthranilic Acid Derivatives as Antagonists of the Pro-Inflammatory Orphan G Protein-Coupled Receptor GPR17","volume":"67","author":"Boshta","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2026.108424_bib48","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.neuron.2020.09.016","article-title":"Robust Myelination of Regenerated Axons Induced by Combined Manipulations of GPR17 and Microglia","volume":"108","author":"Wang","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2026.108424_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111789","article-title":"Design, synthesis and biological evaluation of suramin-derived dual antagonists of the proinflammatory G protein-coupled receptors P2Y2 and GPR17","volume":"186","author":"Pillaiyar","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phrs.2026.108424_bib50","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.chembiol.2018.03.012","article-title":"Repurposing HAMI3379 to Block GPR17 and Promote Rodent and Human Oligodendrocyte Differentiation","volume":"25","author":"Merten","year":"2018","journal-title":"Cell. Chem. Biol."},{"key":"10.1016\/j.phrs.2026.108424_bib51","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1523\/JNEUROSCI.0898-16.2016","article-title":"Olig2-targeted G-protein-coupled receptor Gpr17 regulates oligodendrocyte survival in response to lysolecithin-induced demyelination","volume":"36","author":"Ou","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2026.108424_bib52","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cellsig.2017.04.015","article-title":"Barcoding of GPCR trafficking and signaling through the various trafficking roadmaps by compartmentalized signaling networks","volume":"36","author":"Bahouth","year":"2017","journal-title":"Cell. Signal."},{"key":"10.1016\/j.phrs.2026.108424_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2026.1838997","article-title":"The GPR17 agonist galinex restores oligodendrocyte maturation under inflammatory conditions","volume":"17","author":"Castro e Silva","year":"2026","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108424_bib54","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/humupd\/dmv059","article-title":"GnRH and GnRH receptors in the pathophysiology of the human female reproductive system","volume":"22","author":"Maggi","year":"2016","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.phrs.2026.108424_bib55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clim.2011.05.005","article-title":"Fingolimod in multiple sclerosis: Mechanisms of action and clinical efficacy","volume":"142","author":"Ingwersen","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.phrs.2026.108424_bib56","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMct1101691","article-title":"Fingolimod for Multiple Sclerosis","volume":"366","author":"Pelletier","year":"2012","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.phrs.2026.108424_bib57","doi-asserted-by":"crossref","first-page":"4797","DOI":"10.1111\/bph.12620","article-title":"Investigating the molecular mechanisms through which <scp>FTY<\/scp> 720- <scp>P<\/scp> causes persistent <scp> S1P 1 <\/scp> receptor internalization","volume":"171","author":"Sykes","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108424_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.molpha.2025.100100","article-title":"Constitutive activity among orphan G protein-coupled receptors: Molecular mechanisms and pharmacological perspectives","volume":"108","author":"Murphy","year":"2026","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108424_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41387-019-0096-7","article-title":"Gpr17 deficiency in POMC neurons ameliorates the metabolic derangements caused by long-term high-fat diet feeding","volume":"9","author":"Reilly","year":"2019","journal-title":"Nutr. Diabetes"},{"key":"10.1016\/j.phrs.2026.108424_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.698115","article-title":"Leanness and Low Plasma Leptin in GPR17 Knockout Mice Are Dependent on Strain and Associated With Increased Energy Intake That Is Not Suppressed by Exogenous Leptin","volume":"12","author":"Wargent","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.phrs.2026.108424_bib61","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1016\/j.celrep.2019.02.060","article-title":"A GPR17-cAMP-Lactate Signaling Axis in Oligodendrocytes Regulates Whole-Body Metabolism","volume":"26","author":"Ou","year":"2019","journal-title":"Cell. Rep."},{"key":"10.1016\/j.phrs.2026.108424_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2023.110752","article-title":"Sex differences of microglia in the healthy brain from embryonic development to adulthood and across lifestyle influences","volume":"202","author":"Bobotis","year":"2023","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.phrs.2026.108424_bib63","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41420-025-02425-9","article-title":"Sex and age differences in glia and myelin in nonhuman primate and human spinal cords: implications for pathology","volume":"11","author":"Poulen","year":"2025","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.phrs.2026.108424_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2020.101866","article-title":"Sex-specific differences in transcriptomic profiles and cellular characteristics of oligodendrocyte precursor cells","volume":"46","author":"Yasuda","year":"2020","journal-title":"Stem Cell. Res."},{"key":"10.1016\/j.phrs.2026.108424_bib65","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1111\/bph.14160","article-title":"GPCRs in context: sexual dimorphism in the cardiovascular system","volume":"175","author":"Mouat","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108424_bib66","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3233\/JND-140068","article-title":"Characterization of the Contribution of Genetic Background and Gender to Disease Progression in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis: A Meta-Analysis","volume":"2","author":"Pfohl","year":"2015","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.phrs.2026.108424_bib67","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.neuroscience.2009.08.031","article-title":"Pre-symptomatic detection of chronic motor deficits and genotype prediction in congenic B6.SOD1 ALS mouse model","volume":"164","author":"Hayworth","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2026.108424_bib68","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neurol.2015.11.002","article-title":"Epidemiology of amyotrophic lateral sclerosis: A review of literature","volume":"172","author":"Couratier","year":"2016","journal-title":"Rev. Neurol. (Paris. )."},{"key":"10.1016\/j.phrs.2026.108424_bib69","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.genm.2010.11.010","article-title":"Effects of gender in amyotrophic lateral sclerosis","volume":"7","author":"McCombe","year":"2010","journal-title":"Gend. Med."},{"key":"10.1016\/j.phrs.2026.108424_bib70","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neurol.2019.09.008","article-title":"The effects of diet and sex in amyotrophic lateral sclerosis","volume":"176","author":"Pape","year":"2020","journal-title":"Rev. Neurol. (Paris. )."},{"key":"10.1016\/j.phrs.2026.108424_bib71","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s12035-026-05773-4","article-title":"Neuroinflammation and Oxidative Stress in SOD1 Animal Models of ALS: A Meta-analysis Study of Their Effects on Disease Onset and Progression","volume":"63","author":"Ciuro","year":"2026","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2026.108424_bib72","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/glia.24602","article-title":"Myelin debris phagocytosis in demyelinating disease","volume":"72","author":"Gao","year":"2024","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2026.108424_bib73","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/0271678X221137762","article-title":"The roles of microglia and astrocytes in myelin phagocytosis in the central nervous system","volume":"43","author":"Xu","year":"2023","journal-title":"J. Cereb. Blood Flow. & Metab."},{"key":"10.1016\/j.phrs.2026.108424_bib74","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1084\/jem.20141656","article-title":"Inefficient clearance of myelin debris by microglia impairs remyelinating processes","volume":"212","author":"Lampron","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phrs.2026.108424_bib75","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00401-020-02193-z","article-title":"TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis","volume":"140","author":"Cignarella","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.phrs.2026.108424_bib76","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/brain\/aww298","article-title":"Myelin phagocytosis by astrocytes after myelin damage promotes lesion pathology","volume":"140","author":"Ponath","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2026.108424_bib77","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.4103\/1673-5374.342678","article-title":"Not only myelination: the immune- inflammatory functions of oligodendrocytes","volume":"17","author":"Boccazzi","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.phrs.2026.108424_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.114716","article-title":"Changes in glial cell activation and extracellular vesicles production precede the onset of disease symptoms in transgenic hSOD1G93A pigs","volume":"374","author":"Golia","year":"2024","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2026.108424_bib79","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1474-4422(21)00414-2","article-title":"Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826003397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826003397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T13:23:49Z","timestamp":1794835429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826003397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":79,"alternative-id":["S1043661826003397"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108424","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective targeting of the oligodendroglial GPR17 receptor improves myelin integrity and motor function in female SOD1G93A mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108424","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108424"}}